Hydrocodone Extended-Release Tablets and Xultophy
Determining the interaction of Hydrocodone Extended-Release Tablets and Xultophy and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: hydrocodone
Brand name: Hysingla ER, Zohydro ER, Vantrela ER
Synonyms: Hydrocodone
Generic Name: insulin degludec / liraglutide
Brand name: Xultophy
Synonyms: Xultophy 100/3.6
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Hydrocodone Extended-Release Tablets-Xultophy 100/3.6
- Hydrocodone Extended-Release Tablets-Xuriden
- Hydrocodone Extended-Release Tablets-Xylocaine
- Hydrocodone Extended-Release Tablets-Xylocaine (Cardiac)
- Hydrocodone Extended-Release Tablets-Xylocaine (Lidocaine Injection Solution (Anesthetic))
- Hydrocodone Extended-Release Tablets-Xylocaine (Lidocaine Oral Liquid and Solution)
- Xultophy-Hydrocodone Polistirex and Chlorpheniramine Polistirex Suspension
- Xultophy-Hydrocodone, Chlorpheniramine, and Pseudoephedrine
- Xultophy-Hydrocodone, Pseudoephedrine, and Guaifenesin
- Xultophy-Hydrocortisone
- Xultophy-Hydrocortisone (Systemic)
- Xultophy-Hydrocortisone 2.5%